Status:
UNKNOWN
An Innovation During the Surgical Wait; Evaluation of the Opportunity for Intervention
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Breast Cancer
Eligibility:
FEMALE
19+ years
Brief Summary
The investigators will compare the differences in the scores between the baseline questionnaire (at diagnosis) and the second questionnaire (at treatment) in the RADS II patients that enrolled in pre-...
Eligibility Criteria
Inclusion
- \>18 years of age
- Diagnosis of BI-RADS 4 and 5 (highly suspicious for carcinoma) on an initial imaging
- \>2cm area of disease
- Provide informed consent
Exclusion
- Previous neo-adjuvant therapy
- Patients with recurrent disease
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2017
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02261311
Start Date
March 1 2017
End Date
October 1 2017
Last Update
September 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1Y 4E9